Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer.
Debie, Yana Vandamme, Timon Peeters, Marc
Debie, Yana
Vandamme, Timon
Peeters, Marc
Citations
Altmetric:
Abstract
Description
Date
2022-03-01
Journal Title
Journal ISSN
Volume Title
Publisher
Chapter title
Publication type
Peer reviewed scientific article
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
Antibodies, Viral, Biomarkers, BNT162 Vaccine, COVID-19 Vaccines, Humans, Immunity, Humoral, Immunization Schedule, Immunization, Secondary, Immunogenicity, Vaccine, Neoplasms, Prospective Studies, Risk Factors, Time Factors, Treatment Outcome, Vaccine Efficacy